Sakae Asanuma - Profile and Investment Details

Investor Profile

Sakae Asanuma is a Venture Capital, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Yasuda Enterprise Development, Theolytics, Harpoon Therapeutics, Werewolf Therapeutics, NextCure, Storm Therapeutics, Axial Biotherapeutics, Astellas Venture Management LLC, Anavo Therapeutics, ORIC Pharmaceuticals, Dren Bio, Arcus Biosciences, Orna Therapeutics, Breakpoint Therapeutics, . Over time, Sakae Asanuma has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Sakae Asanuma is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Health and Hospital Services, Reviews and Recommendations, Medical, Therapeutics, Media and Entertainment, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Sakae Asanuma, as their portfolio suggests a familiarity and interest in this area.

Understanding Sakae Asanuma’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.